Diabetes and Mental Health
Open accessAbstract
Monitoring Metabolic RisksYour mental health medications may need to be monitored for possible side effects.Monitoring your glucose levels, lipid levels, blood pressure, and changes in weight will give you peace of mind that your major health risks are being covered.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
People facing diabetes-related stigma in treatment settings show worsening in cardiovascular and metabolic indices.
“People facing diabetes-related stigma in treatment settings show worsening in cardiovascular and metabolic indices [11].”
From Emotional, Psychological, and Social Well-being Experience of Long-Term Living with Type 1 Diabetes Mellitus: A Patient–Psychiatrist–Endocrinologist Perspective (2024) · cites this paper as [11]
The “Stigma: Comorbid Diabetes and Mental Health Issues” section (page not available) says weight-based stigma can occur in health-care settings and can negatively affect health outcomes, including risk of higher blood pressure and decreased glycemic stability. That supports the cardiovascular and metabolic concern, but the passage concerns weight-based stigma specifically and describes risks, not demonstrated worsening of indices among people experiencing diabetes-related stigma generally. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 520 · Cited by 73
Research works printed but not linked: 10
- Shrivastava SR, Prateek Saurabh Shrivastava, and Jegadeesh Ramasamy. Role of self-care in management of diabetes mellitus. Journal of diabetes & Meta- bolic disorders 2013;12(1).
- McCreadie RG. Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study. Br J Psychiatry 2003;183:534e9.
- Wade C, et al. Increased anxiety symptoms in pediatric type 1 diabetes during the acute phase of COVID-19 lockdown. Journal of pediatric endo- crinology & metabolism: JPEM, 2022.
- Silverman ME, et al. The risk factors for postpartum depression: a popula- tion-based study. Depress Anxiety 2017;34(2):178e87.
- Yap JM, et al. Effectiveness of technology-based psychosocial interventions on diabetes distress and health-relevant outcomes among type 2 diabetes mellitus: A systematic review and meta-analysis. Journal of telemedicine and telecare; 2021:1357633X211058329.
- Bush Kea. The AUDIT Alcohol Consumption Questions (AUDIT-C). ARCH INTERN MED; 1998:158.
- Stahl S. The prescriber's guide. 6th ed. New York, NY: Cambridge University Press, 2017.
- Hartling L, et al. Antipsychotics in Adults With Schizophrenia: Com- parativeEffectiveness of First-Generation Versus Second-Gen- erationMedications. Annals of Internal Medicine; 2012.
- Woo V, Harris SB, Houlden RL. Canadian Diabetes Association position paper: Antipsychotic medications and associated risks of weight gain and diabetes. Canadian Journal of Diabetes 2005;29(2):111e2.
- Reynolds GP, Kirk SL. Metabolic side effects of antipsychotic drug treat- mentepharmacological mechanisms. Pharmacology & therapeutics 2010; 125(1):169e79.
- Authors
- Robinson, D. J., Hanson, K., Jain, A. B., Kichler, J. C., Mehta, G., Melamed, O. C., Vallis, M., Bajaj, H. S., Barnes, T., Gilbert, J., Honshorst, K., Houlden, R., Kim, J., Lewis, J., MacDonald, B., MacKay, D., Mansell, K., Rabi, D., Sherifali, D., & Senior, P.
- ORCID
- Venue
- Canadian Journal of Diabetes
- Publisher
- Elsevier BV
- Published
- 2023-06
- Volume
- 47
- Issue
- 4
- Pages
- 308-344
- ISSN
- 1499-2671 (ISSN-L)
- OpenAlex
- W4380738780
- Cited by
- 73
- References
- 520
- Citations by year
- 2026: 19 · 2025: 23 · 2024: 22 · 2023: 4 · 2022: 3 · 2020: 1 · 2018: 1
- FWCI
- 13.95
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Canadian Journal of Diabetes (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- diabetes mellitus, mental health, psychotropic medication side effects, glucose monitoring, serum lipids, blood pressure, weight change
- MeSH terms
- Mental Disorders, Diabetes Mellitus, Type 1, Humans, Mental Health
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
